Summary
The main features of CH50, a recombinant polypeptide of human fibronectin, activating macrophagesin vivo and its anti-tumor function were investigated. After injection of CH50 and (or) transfection of IFN-γ genein vivo, several kinds of factors produced by macrophages were determined and the growth of tumorin vivo was measured. CH50 could enhance the production of such factors as NO, TNF and IL-1 by macrophages, but the activation of macrophages was relatively slow when CH50 was used in vivo alone. CH50 and IFN-γ could synergistically activate macrophages rapidly in vivo no matter whether the injection of CH50 or the transfection of IFN-γ gene was performed first. Injection of CH50 alone inhibited the formation of tumor nodes in a dose-dependent manner. Low dose of CH50 could strongly inhibit the formation of tumor nodes less than 1 mm, while high dose of CH50 could inhibit those more than 1 mm. A stronger inhibition on the growth of tumor in vivo was obtained by the synergistic effect of CH50 and IFN-γ. CH50 and IFN-γ, as double-signal factors for activation of macrophages, will be potentially useful in tumortherapy.
Similar content being viewed by others
References
FN 1996, 12(suppl):121
FN 1998, 27 (1):6
FN CH50 1998, 14(4): 268
Jiao H, Shen W, Ohe Yet al. A new MTT assay for testing macrophage cytotoxicity to L1210 and its drug-resistant cell linesin vitro. Cancer Immunol Immunother, 1992, 35:412
Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods, 1983, 65(1–2):55
J, EF, T, 1992, 792–796
IFN-α 1998, 14(1):22
1996,(4):214
Author information
Authors and Affiliations
Additional information
This project was supported by a grant from the National Natural Sciences Foundation of China (No. 39870763), and a grant from Trans-Century Training Programme Foundation for Talent under the supervision of Ministry of Education of China.
Rights and permissions
About this article
Cite this article
Guimei, Z., Zuohua, F., Dong, L. et al. Effect of polypeptide CH50 on macrophage activationin vivo and antitumor function. Current Medical Science 20, 190–193 (2000). https://doi.org/10.1007/BF02886985
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02886985